DESIGN AND MOLECULAR CHARACTERIZATION OF BIOACTIVE HETEROCYCLIC COMPOUNDS AS POTENTIAL MODULATORS OF GENETIC SIGNALING PATHWAYS

Abstract

Heterocyclic compounds are central to medicinal chemistry because their structural diversity, tunable physicochemical properties, and capacity for selective molecular interactions enable modulation of protein and nucleic acid-associated processes. Despite rapid advances, the field remains fragmented across synthetic chemistry, computational modeling, molecular characterization, signaling biology, and translational pharmacology, limiting integrated interpretation of structure–activity relationships and pathway-level effects. This review critically examines the design, synthesis, characterization, and biological evaluation of bioactive heterocycles as modulators of genetic signaling pathways. Evidence was synthesized from contemporary literature covering nitrogen-, oxygen-, and sulfur-containing, fused, and polycyclic scaffolds; structure-based design; docking and molecular dynamics; spectroscopy and crystallography; and pathway-focused biological studies. The analysis indicates that heterocyclic frameworks can regulate PI3K/AKT/mTOR, RAS/RAF/MEK/ERK, JAK/STAT, Wnt/β-catenin, NF-κB, p53, and related networks through kinase inhibition, transcriptional control, epigenetic modulation, and nucleic acid interactions. Integrated computational and experimental characterization improves target recognition, selectivity, and mechanistic validation, although pathway redundancy, off target effects, resistance, limited bioavailability, and incomplete translation remain major constraints. Future progress will depend on combining artificial intelligence, multi-omics, CRISPR-based validation, biomarker-guided strategies, and precision delivery to develop safer, selective, and clinically relevant heterocyclic signaling modulators. These findings support a chemistry-to-signaling framework linking molecular architecture, target engagement, gene regulation, cellular phenotype, and therapeutic potential.